Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants

Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants
Condition:   Moderate Hepatic Impairment
Intervention:   Drug: Pexidartinib
Sponsor:   Daiichi Sankyo, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 10, 2020 / by / in
Comments